IMMX Financials

Immix Biopharma Inc - Financial statements & key metrics

Stock Price

$9.85

Market Cap

$513.69M

EPS

$-0.89

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-21.70M

EPS (Diluted)

$-0.76

Balance Sheet Highlights

Total Assets

$22.95M

Total Liabilities

$9.70M

Shareholders Equity

Cash & Equivalents

$17.68M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-14.60M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IMMX revenue?

View IMMX's income statement for detailed revenue data.

Is IMMX profitable?

IMMX reported a loss of $21.70M in the most recent quarter.

What is IMMX market cap?

IMMX has a market capitalization of $513.69M, making it a small-cap stock.

Does IMMX have debt?

View IMMX's balance sheet for debt information.

What is IMMX cash flow?

Cash flow data is available in the full financial statements.